Study of [11C]CPPC as a Clinical PET Radioligand Biomarker of Microglial Activation in ALS

NCT05602142 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

ALS

Interventions

DRUG: [11C]CPPC PET ligand

Sponsor

Johns Hopkins University

Collaborators

[object Object]